Back to top
more

Nu Skin Enterprises (NUS)

(Real Time Quote from BATS)

$7.09 USD

7.09
492,662

+0.54 (8.24%)

Updated Nov 11, 2024 12:42 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth F Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 16% (211 out of 250)

Industry: Cosmetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Nu Skin (NUS) Looks Promising: Stock Up More Than 45% in a Year

by Zacks Equity Research

Nu Skin (NUS) is focused on empowering sales leaders and customers through product launches and engaging technology platforms, among other initiatives.

Solid Skin Care & Online Sales Aid The Estee Lauder Companies (EL)

by Zacks Equity Research

The Estee Lauder Companies' (EL) Skin Care portfolio has been performing well for a while now. Also, the company's online operations look impressive.

Vrishali Bagree headshot

4 Cosmetic Stocks to Watch as Consumers Get Ready to Head Out

by Vrishali Bagree

Focus on strengthening brands through innovation and product launches, along with increased use of cosmetics with people gradually stepping out, bodes well for The Estee Lauder (EL), Coty (COTY), Nu Skin (NUS) and Inter Parfums (IPAR).

Inter Parfums (IPAR) Looks Solid, Gains More Than 35% in 6 Months

by Zacks Equity Research

Inter Parfums (IPAR) has been gaining on constant product launches and strategic partnerships. The company's 2021 guidance looks encouraging.

Helen of Troy (HELE) Spins Off Market Personal Care Business

by Zacks Equity Research

Helen of Troy (HELE) divests mass market Personal Care business (excluding the Latin America and Caribbean regions) to HRB Brands LLC as part of its strategy to focus on Leadership Brands.

Zacks Industry Outlook Highlights: Estee Lauder, Coty, Nu Skin and Inter Parfums

by Zacks Equity Research

Zacks Industry Outlook Highlights: Estee Lauder, Coty, Nu Skin and Inter Parfums

    Vrishali Bagree headshot

    4 Cosmetics Stocks Stealing Attention Despite Industry Woes

    by Vrishali Bagree

    The Zacks Cosmetics industry is battling COVID-19 hurdles like disrupted travel retail and low store traffic. However, high demand for personal care products and focus on innovation bodes well for Estee Lauder (EL), Coty (COTY), Nu Skin (NUS) and Inter Parfums (IPAR).

    Nu Skin (NUS) Up 3.8% Since Last Earnings Report: Can It Continue?

    by Zacks Equity Research

    Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

    Coty (COTY) Poised on Strength in Core Priorities & Partnerships

    by Zacks Equity Research

    Coty (COTY) makes several strategic partnerships to enhance its brand portfolio. Also, it is on track with six priorities aimed at sustainable growth.

    Nu Skin (NUS) Looks Buoyant on Product Launches & Online Sales

    by Zacks Equity Research

    Nu Skin (NUS) is benefiting from its focus on innovation and efforts to strengthen sales leader as well as expand customer base.

      The Estee Lauder Companies (EL) Looks Poised on Online Sales

      by Zacks Equity Research

      The Estee Lauder Companies (EL) is benefiting from growing online sales. Also, the company's Skin Care portfolio looks impressive.

      The Estee Lauder Companies (EL) Ups DECIEM Stake, Boosts Skincare

      by Zacks Equity Research

      The Estee Lauder Companies (EL) now has nearly 76% ownership in DECIEM compared with 29% earlier. This is likely to fuel its skincare business.

      Inter Parfums (IPAR) Q1 Earnings Top Estimates, Increase Y/Y

      by Zacks Equity Research

      Inter Parfums' (IPAR) first-quarter 2021 results reflect strong top and bottom lines. Solid performances in regions where lockdowns have been eased benefit results.

      Nu Skin (NUS) Stock Gains on Q1 Earnings Beat & Raised View

      by Zacks Equity Research

      Nu Skin's (NUS) first-quarter 2021 earnings and revenues increase year over year on growth in sales leaders and customer base. Also, management raises 2021 view.

      Nu Skin Enterprises (NUS) Beats Q1 Earnings and Revenue Estimates

      by Zacks Equity Research

      Nu Skin (NUS) delivered earnings and revenue surprises of 26.39% and 6.91%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

      Nu Skin (NUS) to Report Q1 Earnings: What's in the Cards?

      by Zacks Equity Research

      Efforts to strengthen sales leader and expand customer base along with benefits from product innovations are likely to get reflected in Nu Skin's (NUS) first-quarter 2021 performance.

      Nu Skin Enterprises (NUS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

      by Zacks Equity Research

      Nu Skin (NUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

      Inter Parfums (IPAR) Stock Up on Solid Q1 Sales & Raised View

      by Zacks Equity Research

      Inter Parfums (IPAR) sees solid sales growth in the first quarter of 2021, with strength in U.S. and European operations. Further, management raises 2021 view.

      Nu Skin (NUS) Looks Radiant on Innovation & Solid Digital Efforts

      by Zacks Equity Research

      Nu Skin (NUS) is optimistic about momentum in 2021, driven by impressive product pipeline, robust digital efforts along with steady improvement in customers and sales leaders.

      Solid Online Sales Aid Helen of Troy (HELE), Soft Margin a Woe

      by Zacks Equity Research

      Helen of Troy (HELE) is benefiting from solid online operations and Leadership Brands. However, drab operating margin is a headwind.

      Nu Skin (NUS) More Than Doubles in a Year: Innovation a Driver

      by Zacks Equity Research

      Nu Skin (NUS) is optimistic about momentum in 2021, driven by impressive product pipeline, robust digital efforts along with steady improvement in customers and sales leaders.

      Nu Skin (NUS) Down 3.4% Since Last Earnings Report: Can It Rebound?

      by Zacks Equity Research

      Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

      Helen of Troy (HELE) Poised on Leadership Brands, Online Growth

      by Zacks Equity Research

      Helen of Troy (HELE) is focused on making solid investments in its Leadership Brands. Also, it is likely to keep gaining from consistent online sales.

      Nu Skin (NUS) More Than Double in a Year: Will Momentum Stay?

      by Zacks Equity Research

      Nu Skin (NUS) is benefiting from initiatives to strengthen sales leader and expand customer base. Also, the company's focus on digital operations is impressive.

        The Estee Lauder (EL) to Raise Stake in DECIEM to Aid Growth

        by Zacks Equity Research

        The Estee Lauder (EL) will increase its stake in DECIEM from nearly 29% to roughly 76% for almost $1 billion. The deal is likely to be concluded during the quarter ending Jun 30.